PURVI MEHTA: Open Payments
NPI 1730120916 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 36 payments from 12 companies in 2025. Trend: 2023 $455 · 2024 $553 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $174 |
| GlaxoSmithKline, LLC. | 9 | $138 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $108 |
| Amgen Inc. | 5 | $83 |
| GENZYME CORPORATION | 2 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Organon LLC | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: DUPIXENT, NUCALA, NEFFY, TEZSPIRE, FASENRA, KEYTRUDA, TRELEGY ELLIPTA, NEXPLANON.
Industry payments across NC — which companies pay providers there.
